We are live on ! Find out more
BM

Bridger Management Portfolio holdings

AUM $128M
1-Year Est. Return 9.54%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+9.54%
3 Year Est. Return
+98.31%
5 Year Est. Return
+125.76%
10 Year Est. Return
+911.97%
AUM
$156M
AUM Growth
-$30.1M
Cap. Flow
-$36.6M
Cap. Flow %
-23.54%
Top 10 Hldgs %
67.21%
Holding
35
New
7
Increased
3
Reduced
4
Closed
11

Top Buys

1
CX icon
Cemex
CX
+$6.41M
2
CHDN icon
Churchill Downs
CHDN
+$5.93M
3
BIIB icon
Biogen
BIIB
+$5.89M
4
V icon
Visa
V
+$5.86M
5
HQY icon
HealthEquity
HQY
+$5.79M

Sector Composition

1 Healthcare 34.46%
2 Consumer Discretionary 27.31%
3 Financials 19.48%
4 Technology 9.11%
5 Materials 4.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
26
Citigroup
C
$217B
-88,950
Closed -$9.03M
CZR icon
27
Caesars Entertainment
CZR
$6.11B
-247,851
Closed -$6.7M
GDX icon
28
VanEck Gold Miners ETF
GDX
$21.7B
-37,800
Closed -$2.89M
GLD icon
29
SPDR Gold Trust
GLD
$130B
-17,000
Closed -$6.04M
MA icon
30
Mastercard
MA
$479B
-9,310
Closed -$5.3M
MASI
31
DELISTED
Masimo
MASI
-47,841
Closed -$7.06M
NVO
32
Novo Nordisk
NVO
$223B
-103,000
Closed -$5.72M
OSCR icon
33
Oscar Health
OSCR
$8.75B
-248,280
Closed -$4.7M
UNH icon
34
UnitedHealth
UNH
$392B
-16,450
Closed -$5.68M
VRTX icon
35
Vertex Pharmaceuticals
VRTX
$123B
-18,778
Closed -$7.35M

Similar funds

Bridger Management's Q4 2025 Portfolio in Review

As of Q4 2025, Bridger Management held 35 positions worth $156M, down 16% from $186M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Bridger Management withdrew a net $36.6M in Q4 2025, closing 11 positions and reducing 4 holdings. Its most notable exit was Citigroup, an estimated $9.03M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Bridger Management opened a new position in Cemex worth $7.12M.

  • Bridger Management's largest Q4 2025 buy was Cemex: 620,000 shares worth $7.12M.
  • Bridger Management added most to DexCom in Q4 2025, an estimated $3.87M increase.
  • Bridger Management's biggest Q4 2025 reduction was Teva Pharmaceuticals, cutting an estimated $8.07M.
  • Bridger Management fully exited Citigroup in Q4 2025, selling an estimated $9.03M.
  • Bridger Management's ten largest holdings make up 67% of its $156M portfolio in Q4 2025.
  • Bridger Management opened 7 new positions and closed 11 in Q4 2025.
  • Bridger Management's portfolio value fell 16% quarter-over-quarter to $156M.

Based on Bridger Management's 13F filing for Q4 2025, filed 17 Feb 2026.